Literature DB >> 17210634

Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues.

Tiziana Parisi1, Tina L Yuan, Ann Marie Faust, Alicia M Caron, Roderick Bronson, Jacqueline A Lees.   

Abstract

The tumor suppressor function of the retinoblastoma protein pRB is largely dependent upon its capacity to inhibit the E2F transcription factors and thereby cell proliferation. Attempts to study the interplay between pRB and the E2Fs have been hampered by the prenatal death of Rb; E2f nullizygous mice. In this study, we isolated Rb; E2f3 mutant embryonic stem cells and generated Rb(-/-); E2f3(-/-) chimeric mice, thus bypassing the lethality of the Rb(-/-); E2f3(-/-) germ line mutant mice. We show that loss of E2F3 has opposing effects on two of the known developmental defects arising in Rb(-/-) chimeras; it suppresses the formation of cataracts while aggravating the retinal dysplasia. This model system also allows us to assess how E2f3 status influences tumor formation in Rb(-/-) tissues. We find that E2f3 is dispensable for the development of pRB-deficient pituitary and thyroid tumors. In contrast, E2f3 inactivation completely suppresses the pulmonary neuroendocrine hyperplasia arising in Rb(-/-) chimeric mice. This hyperproliferative state is thought to represent the preneoplastic lesion of small-cell lung carcinoma. Therefore, our observation highlights a potential role for E2F3 in the early stages of this tumor type.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210634      PMCID: PMC1820513          DOI: 10.1128/MCB.01854-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

2.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

3.  Extra-embryonic function of Rb is essential for embryonic development and viability.

Authors:  Lizhao Wu; Alain de Bruin; Harold I Saavedra; Maja Starovic; Anthony Trimboli; Ying Yang; Jana Opavska; Pamela Wilson; John C Thompson; Michael C Ostrowski; Thomas J Rosol; Laura A Woollett; Michael Weinstein; James C Cross; Michael L Robinson; Gustavo Leone
Journal:  Nature       Date:  2003-02-27       Impact factor: 49.962

4.  Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice.

Authors:  Alain de Bruin; Lizhao Wu; Harold I Saavedra; Pamela Wilson; Ying Yang; Thomas J Rosol; Michael Weinstein; Michael L Robinson; Gustavo Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

5.  Inactivation of E2F3 results in centrosome amplification.

Authors:  Harold I Saavedra; Baidehi Maiti; Cynthia Timmers; Rachel Altura; Yukari Tokuyama; Kenji Fukasawa; Gustavo Leone
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

6.  E2F4 loss suppresses tumorigenesis in Rb mutant mice.

Authors:  Eunice Y Lee; Hieu Cam; Ulrike Ziebold; Joseph B Rayman; Jacqueline A Lees; Brian David Dynlacht
Journal:  Cancer Cell       Date:  2002-12       Impact factor: 31.743

7.  Nuclear overexpression of the E2F3 transcription factor in human lung cancer.

Authors:  Colin S Cooper; Andrew G Nicholson; Christopher Foster; Andrew Dodson; Sandra Edwards; Anne Fletcher; Toby Roe; Jeremy Clark; Anupam Joshi; Andrew Norman; Andrew Feber; Dongmei Lin; Yanning Gao; Janet Shipley; Shu-Jun Cheng
Journal:  Lung Cancer       Date:  2006-08-30       Impact factor: 5.705

8.  E2f3 is critical for normal cellular proliferation.

Authors:  P O Humbert; R Verona; J M Trimarchi; C Rogers; S Dandapani; J A Lees
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

9.  Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway.

Authors:  Dessislava K Dimova; Olivier Stevaux; Maxim V Frolov; Nicholas J Dyson
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

10.  E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.

Authors:  Ulrike Ziebold; Eunice Y Lee; Roderick T Bronson; Jacqueline A Lees
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more
  28 in total

1.  Closing the phenotypic gap between transformed neuronal cell lines in culture and untransformed neurons.

Authors:  Tereance A Myers; Cheryl A Nickerson; Deepak Kaushal; C Mark Ott; Kerstin Höner zu Bentrup; Rajee Ramamurthy; Mayra Nelman-Gonzalez; Duane L Pierson; Mario T Philipp
Journal:  J Neurosci Methods       Date:  2008-07-10       Impact factor: 2.390

2.  Concomitant inactivation of Rb and E2f8 in hematopoietic stem cells synergizes to induce severe anemia.

Authors:  Tinghui Hu; Seda Ghazaryan; Chandler Sy; Charles Wiedmeyer; Victor Chang; Lizhao Wu
Journal:  Blood       Date:  2012-03-14       Impact factor: 22.113

3.  Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation.

Authors:  A S Landman; P S Danielian; J A Lees
Journal:  Oncogene       Date:  2012-11-12       Impact factor: 9.867

4.  Inactivation of Rb and E2f8 synergizes to trigger stressed DNA replication during erythroid terminal differentiation.

Authors:  Seda Ghazaryan; Chandler Sy; Tinghui Hu; Xiuli An; Narla Mohandas; Haiqing Fu; Mirit I Aladjem; Victor T Chang; Rene Opavsky; Lizhao Wu
Journal:  Mol Cell Biol       Date:  2014-05-27       Impact factor: 4.272

5.  The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation.

Authors:  Björn von Eyss; Jonas Maaskola; Sebastian Memczak; Katharina Möllmann; Anja Schuetz; Christoph Loddenkemper; Mai-Dinh Tanh; Albrecht Otto; Kathrin Muegge; Udo Heinemann; Nikolaus Rajewsky; Ulrike Ziebold
Journal:  EMBO J       Date:  2011-12-13       Impact factor: 11.598

6.  E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.

Authors:  P S Danielian; L B Friesenhahn; A M Faust; J C West; A M Caron; R T Bronson; J A Lees
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

Review 7.  Molecular biology of retinoblastoma.

Authors:  C Sábado Alvarez
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

Review 8.  Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology.

Authors:  Hitoshi Kitamura; Takuya Yazawa; Hanako Sato; Koji Okudela; Hiroaki Shimoyamada
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

9.  Mouse development with a single E2F activator.

Authors:  Shih-Yin Tsai; Rene Opavsky; Nidhi Sharma; Lizhao Wu; Shan Naidu; Eric Nolan; Enrique Feria-Arias; Cynthia Timmers; Jana Opavska; Alain de Bruin; Jean-Leon Chong; Prashant Trikha; Soledad A Fernandez; Paul Stromberg; Thomas J Rosol; Gustavo Leone
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

Review 10.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.